References
- Brogden R N, Ward A. Ceftriaxone: A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once daily administration. Drugs 1988; 35: 604–645
- Arvidsson A, Alvan G, Angelin B, Borga O, Nord C E. Ceftriaxone: renal and biliary excretion and effect on the colon microflora. J Antimicrob Chemother 1982; 10: 207–215
- Veringa E M, van der Waaij D. Biological inactivation by faeces of antimicrobial drugs applicable in selective decontamination of the digestive tract. J Antimicrob Chemother 1983; 14: 605–612
- Meijer-Severs G J, van Santen E, Meijer B C. Short chain fatty acid and organic acid concentrations in feces of healthy human volunteers and their correlation with anaerobe cultural counts during systemic ceftriaxone administration. Scand J Gastroenterol 1990; 25: 698–704
- Nilsson Ehle I, Nord C E, Ursing B. Ceftriaxone: Pharmacokinetics and effect on intestinal microflora in patients with acute bacterial infections. Scand J Infect Dis 1985; 17: 77–82
- Guggenbichler J P, Kofler J, Allerberger F. The influence of third-generation cephalosporins on the aerobic intestinal flora. Infection 1985; 13(Suppl 1)S137–S139
- Bodey G P, Fainstein V, Garcia I, Rosenbaum B, Wong Y. Effect of broad-spectrum cephalosporins on the microflora of recipients. J Infect Dis 1983; 148: 892–897
- Hoepelman I M, Rozenberg-Arska M, Verhoef J. Comparative study of ceftriaxone monotherapy versus a combination regimen of cefuroxime plus gentamicin for treatment of serious bacterial infections: the efficacy, safety and effect on the fecal flora. Chemotherapy 1988; 34(Suppl 1)21–29
- Michéa-Hamzehpour M, Auckentaler R, Kunz J, Pechère J C. Effect of a single dose of ceftriaxone on human fecal flora. A double blind study. Drugs, Suppl 1988; 2: 6–11
- Léonard F, Andremont A, Leclerq B, Labia R, Tancrede C. Use of β-lactamase producing anaerobes to prevent ceftriaxone from degrading intestinal resistance to colonization. J Infect Dis 1989; 160: 274–280
- Yosuji A, Minami S, Inoue M, Mitsuhashi S. Properties of novel β-lactamase produced by Bacteroides fragilis. Antimicrob Agents Chemother 1983; 24: 925–929
- Richards D M, Heel R C, Brogden R N, Speight T M, Avery G S. Ceftriaxone: a review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs 1984; 27: 469–527
- Tunér K, Nord C E. Emergence of β-lactamase producing anaerobic bacteria in the tonsils during penicillin treatment. Eur J Clin Microbiol 1986; 5: 399–404